Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Other Non Operating Income (2018 - 2024)

Historic Other Non Operating Income for International Stem Cell (ISCO) over the last 9 years, with Q4 2024 value amounting to -$1000.0.

  • International Stem Cell's Other Non Operating Income changed N/A to -$1000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $4000.0, marking a year-over-year increase of 3333.33%. This contributed to the annual value of $4000.0 for FY2024, which is 5000.0% down from last year.
  • As of Q4 2024, International Stem Cell's Other Non Operating Income stood at -$1000.0.
  • Over the past 5 years, International Stem Cell's Other Non Operating Income peaked at $661000.0 during Q2 2021, and registered a low of -$8000.0 during Q3 2022.
  • For the 4-year period, International Stem Cell's Other Non Operating Income averaged around $162285.7, with its median value being $5000.0 (2024).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 10168.07% in 2022, then tumbled by 3750.0% in 2024.
  • Quarter analysis of 4 years shows International Stem Cell's Other Non Operating Income stood at $476000.0 in 2021, then tumbled by 101.05% to -$5000.0 in 2022, then soared by 260.0% to $8000.0 in 2023, then tumbled by 112.5% to -$1000.0 in 2024.
  • Its last three reported values are -$1000.0 in Q4 2024, $5000.0 for Q2 2024, and $8000.0 during Q2 2023.